Suntrio Pharma Private Limited
About Suntrio Pharma Private Limited
Data last updated:
Suntrio Pharma Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2021PTC203575.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kamini and Surjeet.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sn – 25 Nanded Phata Nr. Savali Dhaba, Pune, Maharashtra, India – 411041.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.94 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹2,352 (net margin -0.2%) and EBITDA of -₹2,352 (EBITDA margin -0.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Suntrio Pharma Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressSn – 25 Nanded Phata Nr. Savali Dhaba, Pune, Maharashtra, India – 411041
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Suntrio Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Suntrio Pharma Private Limited, buy the company report.
Financials of Suntrio Pharma Private Limited
FY 2025 filings availableSuntrio Pharma Private Limited reported revenue of ₹9.94 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 11% in the latest year. EBITDA fell 361% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2,352 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2,352 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.2% | |||
| Net Profit Margin | -0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Suntrio Pharma Private Limited, buy the company report.
Board of directors of Suntrio Pharma Private Limited
Suntrio Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Peer comparison
Suntrio Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| MPC Healthcare Services Private Limited | ₹9.96 Lakh (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Indigen Biotech Private Limited | ₹9.96 Lakh (FY 2024) | -38.0% | Arani, Tamil Nadu, India | |||
| Norwest Pharmaceuticals Private Limited | ₹9.95 Lakh (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Happie Hemp Private Limited | ₹9.94 Lakh (FY 2024) | -23.0% | Bengaluru, Karnataka, India | |||
| Samruddhi Crop Science Private Limited | ₹9.94 Lakh (FY 2018) | -87.0% | Ahmedabad, Gujarat, India | |||
| Suntrio Pharma Private Limitedthis company | ₹9.94 Lakh (FY 2025) | -₹2,352 | -0.2% | 11.0% | Pune, Maharashtra, India | |
| Yester Pharma Private Limited | ₹9.93 Lakh (FY 2025) | -97.0% | Solan, Himachal Pradesh, India | |||
| Ayu Swasth Private Limited | ₹9.91 Lakh (FY 2023) | 105.0% | Faridabad, Haryana, India | |||
| Orgera Healthcare Private Limited | ₹9.9 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Niharith Pharma Private Limited | ₹9.9 Lakh (FY 2020) | Dehradun, Uttarakhand, India | ||||
| Moshi Pathology Lab and Diagnostic Centre Private Limited | ₹9.89 Lakh (FY 2025) | -72.0% | Pune, Maharashtra, India |
To see the full peer comparison of Suntrio Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Suntrio Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suntrio Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Suntrio Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Suntrio Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Shalini Singh ceased to be Director on 18 Sep 2025.
Frequently asked questions
Suntrio Pharma is an active private limited company based in Pune, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 August 2021 (5+ years old) and is registered under CIN U24290PN2021PTC203575.
The latest financial statements of Suntrio Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Suntrio Pharma is U24290PN2021PTC203575. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suntrio Pharma was incorporated on 19 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Suntrio Pharma by revenue are MPC Healthcare Services Private Limited, Indigen Biotech Private Limited, Norwest Pharmaceuticals Private Limited, Happie Hemp Private Limited, Samruddhi Crop Science Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shalini Singh ceased to be Director on 18 Sep 2025. Surjeet was appointed as Director on 18 Sep 2025. Kamini was appointed as Director on 19 Aug 2021. Suntrio Pharma has 4 board changes on record in total.
The registered office of Suntrio Pharma is at Sn – 25 Nanded Phata Nr. Savali Dhaba, Pune, Maharashtra, India – 411041.
Suntrio Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Suntrio Pharma is compliant as of 13 August 2026. The company is actively filing with the Registrar of Companies.
Suntrio Pharma can be reached at its registered office: Sn – 25 Nanded Phata Nr. Savali Dhaba, Pune, Maharashtra, India – 411041.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
